Inventor · Moraga, CA, US

Mark K. Bennett

35Patents
7h-index
21Co-inventors
65Inventor score

Filing activity: Mar 15, 2002 → Feb 1, 2019

Most-cited inventions

PatentTitleAreaCited byStatus
US7691852B2 Compounds for enzyme inhibition Emerging Cross-Sectional Technologies 49 Active
US8080576B2 Compounds for enzyme inhibition Emerging Cross-Sectional Technologies 32 Active
US8080545B2 Compounds for enzyme inhibition Emerging Cross-Sectional Technologies 31 Active
US8357683B2 Compounds for enzyme inhibition Emerging Cross-Sectional Technologies 29 Active
US8431571B2 Compounds for enzyme inhibition Emerging Cross-Sectional Technologies 28 Active
US7252952B2 In vivo production of cyclic peptides for inhibiting protein—protein interaction Physics 8 Expired
US8609654B1 Compounds for enzyme inhibition Emerging Cross-Sectional Technologies 8 Active
US8895034B2 Collagen production compound Human Necessities 7 Active
US9511109B2 Combination therapy with peptide epoxyketones Human Necessities 5 Active
US7378248B2 In vivo production of cyclic peptides for inhibiting protein-protein interaction Chemistry; Metallurgy 4 Expired
US9040462B2 In vivo production of cyclic peptides for inhibiting protein-protein interaction Chemistry; Metallurgy 4 Active
US7741432B2 Substrate for Rpn11 enzymatic activity Physics 3 Active
US7071190B2 Inhibitors to tubulin polymerization Chemistry; Metallurgy 3 Expired
US10258619B2 Combination therapy with glutaminase inhibitors and immuno-oncology agents Chemistry; Metallurgy 3 Active
US6979549B2 Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a CLLD8 protein Emerging Cross-Sectional Technologies 3 Expired
US7425418B2 Compounds that modulate processes associated with IgE production Physics 2 Expired
US7604951B2 Method for identifying compounds that modulate RXR associated processes with IgE production Physics 1 Active
US8765745B2 Compounds for enzyme inhibition Emerging Cross-Sectional Technologies 1 Active
US7598050B2 Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a chloride intracellular channel 1 protein Physics 1 Active
US7378251B2 Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a thioredoxin-like 32 kDa protein Human Necessities 1 Expired
US7422867B2 Methods of identifying compounds that modulate IL-4 receptor mediated IgE synthesis utilizing a CLLD8 protein Emerging Cross-Sectional Technologies 0 Active
US9657058B2 Compounds for enzyme inhibition Emerging Cross-Sectional Technologies 0 Active
US10940148B2 Combination therapy with glutaminase inhibitors and immuno-oncology agents Chemistry; Metallurgy 0 Active
US9359398B2 Compounds for immunoproteasome inhibition Chemistry; Metallurgy 0 Active
USRE47954E1 Combination therapy with peptide epoxyketones General 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.